XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Equity-Based Compensation - Summary of Stock Option Activity (Details) - Stock Options [Member] - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Options, Outstanding, Beginning balance 2,300,819  
Number of Options, Granted 1,081,437  
Number of options, Forfeited (6,500)  
Number of Options, Outstanding, Ending balance 3,375,756 2,300,819
Exercisable at March 31, 2022 133,775  
Nonvested at March 31, 2022 3,241,981  
Weighted Average Exercise Price per Share, Outstanding, Beginning balance $ 14.12  
Weighted Average Exercise Price per Share, Granted 13.38  
Weighted Average Exercise Price per Share, Forfeited 26.78  
Weighted Average Exercise Price per Share, Outstanding, Ending balance 13.86 $ 14.12
Weighted Average Exercise Price per Share, Exercisable at March 31, 2022 9.44  
Weighted Average Exercise Price per Share, Nonvested at March 31, 2022 $ 14.04  
Weighted Average Remaining Contractual Term (in years) 9 years 6 months 10 days 9 years 6 months 18 days
Weighted Average Remaining Contractual Term, Granted (in years) 9 years 11 months 15 days  
Weighted Average Remaining Contractual Term, Exercisable at March 31, 2022 (in years) 9 years 2 months 15 days  
Weighted Average Remaining Contractual Term, Nonvested at March 31, 2022 (in years) 9 years 6 months 14 days  
Aggregate Intrinsic Value, Outstanding, Beginning Balance $ 976  
Aggregate Intrinsic Value, Granted (in thousands) 299  
Aggregate Intrinsic Value, Outstanding, Ending Balance 5,677 $ 976
Aggregate Intrinsic Value, Exercisable at March 31, 2022 (in thousands) 543  
Aggregate Intrinsic Value, Nonvested at March 31, 2022 (in thousands) $ 5,134